Peter Cage
9Patents
6h-index
19Co-inventors
56Inventor score
Filing activity: Jun 6, 1995 → Dec 10, 2008
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5721219A | N-alkyl-2-substituted ATP analogues and administration to inhibit platelet aggregation | Chemistry; Metallurgy | 52 | Expired |
| US5955447A | N-alkyl-2-substituted ATP analogues for treatment of embolic disease conditions | Chemistry; Metallurgy | 30 | Expired |
| US7902181B2 | Compounds 010 | Chemistry; Metallurgy | 18 | Active |
| US5654285A | ADP and ATP analogues, process for making and administration to inhibit ADP-induced platelet aggregation | Chemistry; Metallurgy | 16 | Expired |
| US7956070B2 | Piperidines as chemokine modulators (CCR) | Chemistry; Metallurgy | 16 | Active |
| US6958344B2 | Pyrimidine compounds and their use as modulators of chemokine receptor activity | Human Necessities | 7 | Expired |
| US5846989A | Benzothiazolone derivatives | Chemistry; Metallurgy | 6 | Expired |
| US6958343B2 | Thiazolopyrimidines and their use as modulators of chemokine receptor activity | Human Necessities | 5 | Expired |
| US5929100A | Biologically active benzothiazolone ethanamines | Human Necessities | 4 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.